Michael Klichinsky
0000-0001-8935-163X
Publication & Citation Trends
Publications
0 total
In vivo chimeric antigen receptor (CAR)-T cell therapy
Cited by 35
Semantic Scholar
Chimeric antigen receptor macrophages (CAR-M) sensitize HER2+ solid tumors to PD1 blockade in pre-clinical models OA
Cited by 66
Semantic Scholar
Abstract P2-12-17: A Phase 1, First-in-Human study of autologous monocytes engineered to express an anti-HER2 chimeric antigen receptor (CAR) in participants with HER2 overexpressing solid tumors
Cited by 0
Semantic Scholar
CAR-macrophage therapy for HER2-overexpressing advanced solid tumors: a phase 1 trial
Cited by 130
Semantic Scholar
FRI-041 Enhancing restorative macrophage functions through genetic modification improves liver fibrosis in MASH models
Cited by 0
Semantic Scholar
Impaired TIM4-mediated efferocytosis by liver macrophages contributes to fibrosis in metabolic dysfunction-associated steatohepatitis.
Cited by 8
Semantic Scholar
Abstract PO2-04-08: Translational insights from a phase 1, first-in-human (FIH) clinical trial of the anti-HER2 CAR macrophage CT-0508 in participants with HER2 positive metastatic breast cancer and other HER2 overexpressing solid tumors
Cited by 4
Semantic Scholar
Abstract 5249: Macrophages expressing synthetic cytokine receptors reverse IL10-mediated immunosuppression within solid tumors and promote adaptive immunity
Cited by 3
Semantic Scholar
Research Topics
CAR-T cell therapy research
(74)
Immune cells in cancer
(26)
Monoclonal and Polyclonal Antibodies Research
(20)
Phagocytosis and Immune Regulation
(18)
Immunotherapy and Immune Responses
(14)
Affiliations
The Wistar Institute
California University of Pennsylvania
Pulmonary and Allergy Associates
Ark Therapeutic (United States)
Translational Therapeutics (United States)